NO20043548L - Anvendelse av flerumettede katoner for behandling av psoriasis - Google Patents

Anvendelse av flerumettede katoner for behandling av psoriasis

Info

Publication number: NO20043548L
Authority: NO; Norway
Prior art keywords: psoriasis; treatment; group; polyunsaturated; cotton
Prior art date: 2002-01-29

Application number

NO20043548A

Other languages

English (en)

Other versions

NO334413B1 (no

Inventor

Berit Johansen

Marit Anthonsen

Wenche Sjursen

Anne Kristen Holmeide

Lars Skattebol

Original Assignee

Avexxin As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-01-29

Filing date

2004-08-25

Publication date

2004-08-25

2004-08-25 Application filed by Avexxin As filed Critical Avexxin As

2004-08-25 Publication of NO20043548L publication Critical patent/NO20043548L/no

2014-02-24 Publication of NO334413B1 publication Critical patent/NO334413B1/no

Links

201000004681 Psoriasis Diseases 0.000 title abstract 3
229920000742 Cotton Polymers 0.000 title 1
125000005842 heteroatom Chemical group 0.000 abstract 2
125000001183 hydrocarbyl group Chemical group 0.000 abstract 2
125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
230000001684 chronic effect Effects 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
125000006575 electron-withdrawing group Chemical group 0.000 abstract 1
230000002757 inflammatory effect Effects 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
208000017520 skin disease Diseases 0.000 abstract 1
229930195735 unsaturated hydrocarbon Natural products 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/121—Ketones acyclic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Dermatology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

NO20043548A 2002-01-29 2004-08-25 Flerumettede ketoner ved fremstilling av medikamenter for behandling av psoriasis samt farmasøytisk preparat omfattende samme NO334413B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0202002.2A GB0202002D0 (en)	2002-01-29	2002-01-29	Use
PCT/GB2003/000364 WO2003063878A1 (en)	2002-01-29	2003-01-29	Use of polyunsaturated ketones for the treatment of psoriasis

Publications (2)

Publication Number	Publication Date
NO20043548L true NO20043548L (no)	2004-08-25
NO334413B1 NO334413B1 (no)	2014-02-24

Family

ID=9929945

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20043548A NO334413B1 (no)	2002-01-29	2004-08-25	Flerumettede ketoner ved fremstilling av medikamenter for behandling av psoriasis samt farmasøytisk preparat omfattende samme

Country Status (14)

Country	Link
US (4)	US7687543B2 (no)
EP (1)	EP1469859B1 (no)
JP (1)	JP4608214B2 (no)
KR (1)	KR100874505B1 (no)
CN (2)	CN1678323A (no)
AT (1)	ATE535245T1 (no)
AU (1)	AU2003206999B2 (no)
CA (1)	CA2473687C (no)
DK (1)	DK1469859T3 (no)
ES (1)	ES2378303T3 (no)
GB (1)	GB0202002D0 (no)
NO (1)	NO334413B1 (no)
PT (1)	PT1469859E (no)
WO (1)	WO2003063878A1 (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2248798A1 (en) *	2009-05-08	2010-11-10	Pronova BioPharma Norge AS	Novel lipid compounds
GB0909643D0 (en) *	2009-06-04	2009-07-22	Avexxin As	Glomerulonephritis treatment
JP6012468B2 (ja) *	2009-10-02	2016-10-25	アヴェクシンエーエス	抗炎症性２−オキソチアゾールおよび２−オキソオキサゾール
GB201014633D0 (en) *	2010-09-02	2010-10-13	Avexxin As	Rheumatoid arthritis treatment
NZ610705A (en)	2010-11-05	2014-10-31	Pronova Biopharma Norge As	Methods of treatment using lipid compounds
GB201205394D0 (en)	2012-03-27	2012-05-09	Adlens Ltd	Improvements in or relating to deformable non-round membrane assemblies
GB201221329D0 (en) *	2012-11-27	2013-01-09	Avexxin As	Dermatitis treatment
CN105102438B (zh)	2013-01-29	2019-04-30	埃维克辛公司	抗炎症和抗肿瘤的2-氧代噻唑类和2-氧代噻吩类化合物
AU2014222389B2 (en)	2013-02-28	2018-11-29	Pronova Biopharma Norge As	A composition comprising a lipid compound, a triglyceride, and a surfactant, and methods of using the same
GB201313238D0 (en)	2013-07-24	2013-09-04	Avexxin As	Process for the preparation of a polyunsaturated ketone compound
GB201409363D0 (en) *	2014-05-27	2014-07-09	Avexxin As	Skin cancer treatment
GB201413695D0 (en)	2014-08-01	2014-09-17	Avexxin As	Compound
GB201501144D0 (en)	2015-01-23	2015-03-11	Avexxin As	Process for the preparation of a polyunsaturated ketone compound
US20180104201A1 (en)	2015-04-28	2018-04-19	Pronova Biopharma Norge As	Use of structurally enhanced fatty acids containing sulphur for preventing and or treating non alcoholic steatohepatitis
GB201604318D0 (en)	2016-03-14	2016-04-27	Avexxin As	Combination therapy
GB201604316D0 (en)	2016-03-14	2016-04-27	Avexxin As	Combination therapy
KR20190015320A (ko) *	2016-06-03	2019-02-13	아벡신 에이에스	다중불포화 케톤 및 코르티코스테로이드를 포함하는 조합 치료요법
CA3025696A1 (en) *	2016-06-03	2017-12-07	Avexxin As	Combination therapy comprising a polyunsaturated ketone and a secosteroid
GB201609735D0 (en) *	2016-06-03	2016-07-20	Avexxin As	Combination therapy
CA3025698A1 (en) *	2016-06-03	2017-12-07	Avexxin As	Combination therapy comprising a polyunsaturated ketone and a calcineurin inhibitor
CN109789111B (zh) *	2016-09-21	2021-11-16	埃维克辛公司	药物组合物
EP3638221B1 (en) *	2017-06-16	2021-09-29	Avexxin AS	Compositions and methods for treatment of a fibrotic disease
PT3720431T (pt)	2017-12-06	2024-12-05	Basf As	Derivados de ácidos gordos para o tratamento da esteato-hepatite não alcoólica
GB201807892D0 (en)	2018-05-15	2018-06-27	Avexxin As	Processes in the preparation of polyunsaturated ketone compounds
GB202020843D0 (en)	2020-12-31	2021-02-17	Coegin Pharma Ab	Actinic keratosis treatment

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH09268153A (ja) *	1996-04-02	1997-10-14	Sagami Chem Res Center	トリフルオロメチルケトン誘導体及びホスホリパーゼａ２阻害剤
AU730364B2 (en) *	1997-09-23	2001-03-08	Bristol-Myers Squibb Company	Selective cPLA2 inhibitors
JPH11199493A (ja) *	1997-11-13	1999-07-27	Nof Corp	皮膚外用剤組成物
AU4994899A (en)	1998-07-13	2000-02-01	University Of South Florida	Modulation of the phospholipase a2 pathway as a therapeutic
US20020165119A1 (en)	2001-01-31	2002-11-07	Alan Leff	Method of treating inflammatory conditions by inhibiting cytosolic phospholipase A2
EP1243524A3 (en) *	2001-03-16	2004-04-07	Pfizer Products Inc.	Pharmaceutical kit for oxygen-sensitive drugs
US20040111957A1 (en) *	2002-12-13	2004-06-17	Filippini Brian B.	Water blended fuel composition

2002
- 2002-01-29 GB GBGB0202002.2A patent/GB0202002D0/en not_active Ceased
2003
- 2003-01-29 DK DK03704739.6T patent/DK1469859T3/da active
- 2003-01-29 JP JP2003563568A patent/JP4608214B2/ja not_active Expired - Fee Related
- 2003-01-29 CN CNA038028999A patent/CN1678323A/zh active Pending
- 2003-01-29 AU AU2003206999A patent/AU2003206999B2/en not_active Ceased
- 2003-01-29 AT AT03704739T patent/ATE535245T1/de active
- 2003-01-29 CA CA2473687A patent/CA2473687C/en not_active Expired - Fee Related
- 2003-01-29 KR KR1020047011693A patent/KR100874505B1/ko not_active Expired - Fee Related
- 2003-01-29 WO PCT/GB2003/000364 patent/WO2003063878A1/en not_active Ceased
- 2003-01-29 US US10/502,414 patent/US7687543B2/en not_active Expired - Fee Related
- 2003-01-29 PT PT03704739T patent/PT1469859E/pt unknown
- 2003-01-29 ES ES03704739T patent/ES2378303T3/es not_active Expired - Lifetime
- 2003-01-29 EP EP03704739A patent/EP1469859B1/en not_active Expired - Lifetime
- 2003-01-29 CN CN201010129984A patent/CN101849929A/zh active Pending
2004
- 2004-08-25 NO NO20043548A patent/NO334413B1/no not_active IP Right Cessation
2010
- 2010-02-26 US US12/713,917 patent/US8524776B2/en not_active Expired - Fee Related
2013
- 2013-08-02 US US13/957,899 patent/US8865768B2/en not_active Expired - Lifetime
2014
- 2014-09-16 US US14/487,382 patent/US9375409B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CA2473687A1 (en)	2003-08-07
AU2003206999B2 (en)	2007-12-13
US8865768B2 (en)	2014-10-21
US7687543B2 (en)	2010-03-30
JP2005518419A (ja)	2005-06-23
KR20040089127A (ko)	2004-10-20
DK1469859T3 (da)	2012-03-19
JP4608214B2 (ja)	2011-01-12
GB0202002D0 (en)	2002-03-13
US20150202165A1 (en)	2015-07-23
NO334413B1 (no)	2014-02-24
US20100152293A1 (en)	2010-06-17
EP1469859A1 (en)	2004-10-27
KR100874505B1 (ko)	2008-12-18
PT1469859E (pt)	2012-03-06
EP1469859B1 (en)	2011-11-30
CA2473687C (en)	2011-04-12
ATE535245T1 (de)	2011-12-15
CN1678323A (zh)	2005-10-05
ES2378303T3 (es)	2012-04-11
US8524776B2 (en)	2013-09-03
CN101849929A (zh)	2010-10-06
US20050165116A1 (en)	2005-07-28
US9375409B2 (en)	2016-06-28
US20130324613A1 (en)	2013-12-05
WO2003063878A1 (en)	2003-08-07

Legal Events

Date	Code	Title	Description
2020-08-24	MM1K	Lapsed by not paying the annual fees

Publication	Publication Date	Title
GB0202002D0 (en)	2002-03-13	Use
SE0301882D0 (sv)	2003-06-25	New use I
SE0301888D0 (sv)	2003-06-25	New use VII
BRPI0006634B8 (pt)	2021-05-25	composição tópica compreendendo extrato de matricária no tratamento e prevenção de distúrbios inflamatórios
MY147643A (en)	2012-12-31	Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
PT1227820E (pt)	2006-08-31	Acidos oligossacarido-aldonicos e sua utilizacao topica
ATE539751T1 (de)	2012-01-15	Verwendung von brimonidine zur behandlung von stress assoziierten zuständen
UY28081A1 (es)	2004-06-30	Administracinn combinada de una indolinona con un agente quimioterapcutico para trastornos de proliferacinn celular
ATE355056T1 (de)	2006-03-15	Jasmonate enthaltende therapeutische zusammensetzungen für die behandlung von krebs
DE60231050D1 (de)	2009-03-19	Verwendung von Totarol zur Behandlung von Pruritus
SE0300971D0 (sv)	2003-04-03	Nitric oxide in treatment of inflammation
NO20025510D0 (no)	2002-11-15	Tienodibenzoazulenforbindelser som tumor nekrose faktor inhibitorer
BR0316723A (pt)	2005-10-18	Derivados de anilinopirazol úteis para o tratamento de diabetes
DE602004015406D1 (de)	2008-09-11	Verwendung von 3-methoxy-pregnenolon bei der herstellung eines arzneimittels zur behandlung von neurodegenerativen erkrankungen
DE602004023762D1 (de)	2009-12-03	Für die behandlung von alzheimer-krankheit und ähnlichen leiden geeignete 1-alkyl-3-thiosubstituierte indol-2-alkinsäuren
ES2106531T3 (es)	1997-11-01	Compuestos de dibenzoxazepina substituidos en 2, 3, 4, 5, 6, 7, 8, 9 y/o 10, composiciones farmaceuticas y metodos de uso.
SE9601677D0 (sv)	1996-05-02	New use
DE60016181D1 (de)	2004-12-30	C-16 ungesätigte fp-selektive prostaglandin analoge
SE0004101D0 (sv)	2000-11-09	New use
ATE539749T1 (de)	2012-01-15	Dextromethorphan für die behandlung von akne
DE60230155D1 (de)	2009-01-15	Verwendung von verzweigtkettigen fettsäuren und ihrer derivate zur schmerzbehandlung
BR0309996A (pt)	2005-02-22	Composto, composição farmacêutica, método de tratar ou melhorar doenças ou condições proliferativas, uso de um composto, e, método de tratar ou melhorar doenças inflamatórias
SE0301883D0 (sv)	2003-06-25	New use II
RU2007138263A (ru)	2009-04-27	Противовоспалительные соединения
SE0301885D0 (sv)	2003-06-25	New use IV